comparemela.com

Latest Breaking News On - Diagnostics market size - Page 13 : comparemela.com

Rabies Diagnostics Market Worth USD 2 38 Billion by 2028 Growing at 4 4% CAGR Says Reports And Data

Rabies Diagnostics Market Worth USD 2.38 Billion by 2028 Growing at 4.4% CAGR Says Reports And Data iCrowd Newswire 14 Jul 2021, 10:09 GMT+10 Rising prevalence of neglected tropical diseases (NTDs) worldwide coupled with growing demand for advanced rabies diagnostic solutions to boost market growth Rabies Diagnostics Market Size – USD 1.69 billion in 2020, Industry Growth – at a CAGR of 4.4%, Trends – Rising initiatives to develop novel rabies detection assays The global rabies diagnostics market size is expected to reach USD 2.38 billion by 2028 at a CAGR of 4.4% according to the latest report by Reports and Data. The most critical parameters influencing the global market growth are rising prevalence of infectious animal-transmitted diseases such as rabies and neglected tropical diseases (NTDs) worldwide, increasing awareness programs about infectious diseases, and growing number of rabies diagnostic tests.

United States Tissue Diagnostics Market Report 2021-2028: Market Players are Investing Significantly in Novel Product Development and Acquisition of Small Players

United States Tissue Diagnostics Market Report 2021-2028: Market Players are Investing Significantly in Novel Product Development and Acquisition of Small Players
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Worldwide Multiplexed Diagnostics Industry to 2029 - by Product Type, Technology, Application and Geography

Share this article Share this article ResearchAndMarkets.com s offering. Multiplexed diagnostics can detect multiple analytes in a sample through a single run. Multiplexed assays are used in the detection of cancers, infectious diseases and functional biomolecules such as (DNA and mRNA). Multiplexed assays aid in disease diagnosis, molecular diagnosis, and drug development. Multiplexed diagnostics is capable to detect analytes in the limited sample and in short span of time by analyzing hundreds of data points simultaneously. Global multiplexed diagnostics market comprise of reagent and consumables, and analyzers. This report includes a comprehensive market analysis of the global multiplexed diagnostics market for the period 2019 - 2029. Key insights discussed in this report will provide market stakeholders complete understanding of the market and aids in market initiatives including product launch and investment areas.

Infectious Disease POC Diagnostics Market Size 2021 | Is Projected to Reach USD 3,371 1 Million with 17 4% CAGR by 2027

Bio-Rad Laboratories Inc. (California, U.S) Other Players Market Penetration: Comprehensive information on the product portfolios of the top players in the market. Product Development/Innovation: Detailed insights on the upcoming technologies, RandD activities, and product launches in the market Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the market Industry Developments: June 2020 - Cepheid announced launch of Xpert Xpress SARS-CoV-2/Flu/RSV a four in one combination test used for the detection of detection of SARS-CoV-2, Flu A, Flu B and RSV from a sample of single patient.

Global infectious diseases in-vitro diagnostics market size to expand at 3 8% CAGR through 2027

Global infectious diseases in-vitro diagnostics market size to expand at 3.8% CAGR through 2027 The research report on ‘global infectious diseases in-vitro diagnostics (IVD) market’ talks about the several trends prevailing in this business sphere, such as the growth stimulants, challenges faced by the industry participants, and other revenue generation opportunities. Selbyville, Delaware, April 28, 2021 (GLOBE NEWSWIRE) As per reliable analysts, global infectious diseases in-vitro diagnostics market size was appraised at USD 54 billion in the year 2019 and is expected to register a y-o-y growth rate of 3.8% during 2020-2027, subsequently accounting for USD 73 billion by the year 2027. Shifting preferences towards adopting point-of-care diagnostic tools, high occurrence of infectious diseases, and favorable government regulations have resulted in increased product penetration across the globe.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.